​

Soleno Therapeutics Ownership | Who Owns Soleno Therapeutics?

OverviewForecastFinancialsChartTranscripts

Soleno Therapeutics Ownership Summary

Soleno Therapeutics is owned by 118.17% institutional investors, 1.85% insiders. Vivo capital is the largest institutional shareholder, holding 15.02% of SLNO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.28% of its assets in Soleno Therapeutics shares.

SLNO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockSoleno Therapeutics118.17%1.85%-20.02%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vivo capital6.29M15.02%$282.82M
Janus henderson group5.19M12.39%$233.13M
Nantahala capital management3.93M9.38%$176.61M
Adage capital partners gp2.78M6.63%$124.78M
Avoro capital advisors2.52M6.03%$113.50M
Blackrock1.86M5.15%$76.03M
Blackrock funding, inc. /de2.01M4.80%$90.34M
Vanguard group1.88M4.50%$84.71M
Price t rowe associates inc /md/1.63M3.89%$73.30M
Commodore capital lp1.52M3.64%$68.55M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Vivo capital6.29M31.68%$282.82M
Artia global partners lp494.42K7.94%$22.22M
Nantahala capital management3.93M7.58%$176.61M
Commodore capital lp1.52M5.02%$68.55M
Ghost tree capital300.00K3.83%$12.24M
Ally bridge group (ny)87.63K3.38%$3.94M
Nan fung group79.65K3.06%$3.58M
Exome asset management77.28K2.61%$3.47M
Sofinnova investments757.25K2.48%$34.04M
Tcg crossover management550.00K2.42%$24.72M

Top Buyers

HolderShares% AssetsChange
Blackrock1.86M0.00%1.54M
Janus henderson group5.19M0.12%1.11M
Nantahala capital management3.93M7.58%658.52K
Westfield capital management co lp881.46K0.17%385.75K
Holocene advisors, lp955.47K0.14%361.10K

Top Sellers

HolderShares% AssetsChange
Carlyle group1.38M1.49%-2.70M
Perceptive advisors1.50M1.86%-1.70M
Vestal point capital, lp---1.06M
Assenagon asset management---729.84K
Alyeska investment group424.08K0.07%-552.02K

New Positions

HolderShares% AssetsChangeValue
Siren351.82K0.70%351.82K$15.81M
Logos global management lp350.00K1.84%350.00K$15.73M
Timessquare capital management339.77K0.22%339.77K$15.27M
Pfm health sciences, lp307.50K0.86%307.50K$13.82M
Rock springs capital management lp124.09K0.21%124.09K$5.58M

Sold Out

HolderChange
National bank of canada /fi/-1.00
Ifp advisors-4.00
Harbour investments-5.00
Smartleaf asset management-9.00
Quantbot technologies lp-9.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202526035.42%54,569,8436.92%1180.80%14512.40%59110.71%
Dec 31, 202449-68.59%6,917,396-85.32%160.13%35-66.02%6-75.00%
Sep 30, 202415631.09%47,121,2808.78%1120.79%10330.38%24-4.00%
Jun 30, 202411910.19%43,316,98021.90%1191.24%793.95%2566.67%
Mar 31, 202410828.57%35,536,01513.14%981.18%7635.71%1515.38%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.14M2.28%3.49K
Vanguard US Total Market Shares ETF913.59K1.99%-
Janus Henderson Global Life Sciences D923.65K1.85%-3.42K
Janus Henderson Global Life Sciences923.65K1.83%-9.65K
T. Rowe Price US All-Cap Opp Eq Comp732.72K1.60%397.00K
T. Rowe Price All-Cap Opportunities Fund732.72K1.60%365.30K
Janus Global Life Science AUSD749.01K1.50%10.14K
Polar Capital Biotech S Inc750.00K1.49%250.00K
Janus Henderson Glb Life Scn I2 USD744.52K1.48%-4.49K
iShares Russell 2000 ETF653.79K1.30%321.00

Recent Insider Transactions

DateNameRoleActivityValue
Apr 01, 2025Hirano Patricia C SEE REMARKSSell$265.16K
Mar 28, 2025Pauls Matthew-Sell$424.80K
Mar 27, 2025Yen Kristen SEE REMARKSSell$116.70K
Mar 27, 2025Yen Kristen SEE REMARKSSell$192.43K
Mar 27, 2025Yen Kristen SEE REMARKSSell$354.68K

Insider Transactions Trends

DateBuySell
2025 Q2-1
2025 Q1-83
2024 Q4-8
2024 Q3-47
2024 Q2-10

SLNO Ownership FAQ

Who Owns Soleno Therapeutics?

Soleno Therapeutics shareholders are primarily institutional investors at 118.17%, followed by 1.85% insiders and -20.02% retail investors. The average institutional ownership in Soleno Therapeutics's industry, Biotech Stocks , is 63.96%, which Soleno Therapeutics exceeds.

Who owns the most shares of Soleno Therapeutics?

Soleno Therapeutics’s largest shareholders are Vivo capital (6.29M shares, 15.02%), Janus henderson group (5.19M shares, 12.39%), and Nantahala capital management (3.93M shares, 9.38%). Together, they hold 36.79% of Soleno Therapeutics’s total shares outstanding.

Does Blackrock own Soleno Therapeutics?

Yes, BlackRock owns 5.15% of Soleno Therapeutics, totaling 1.86M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 76.03M$. In the last quarter, BlackRock increased its holdings by 1.54M shares, a 471.09% change.

Who is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is Soleno Therapeutics’s biggest shareholder by percentage of total assets invested, with 31.68% of its assets in 6.29M Soleno Therapeutics shares, valued at 282.82M$.

Who is the top mutual fund holder of Soleno Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Soleno Therapeutics shares, with 2.28% of its total shares outstanding invested in 1.14M Soleno Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools